Hosted by Unknown Host · EN · 28 episodes
Established thought leaders with verified media credentials.
In this podcast, the International Association of Liver Cancer (ILCA) will cover the most recent papers in liver cancer research and some of the key sessions from industry events. Join in for an interactive summary of the latest in liver cancer and hear from our ILCA experts as well as some special guests!
Unknown Host hosts Liver Cancer Podcast, a business show with 28 episodes published.
Season 3 - Episode 10 In this episode, Dr. Manon Allaire, a physician at La Pitié-Salpêtrière Hospital in Paris, shares her perspective on evolving approaches in liver cancer care. Using the CHIEF data as a starting poin
Season 4 - Episode 2 In the second episode of ILCA’s Liver Cancer Podcast, hosted by Sarah Cappuyns, MD, PhD, a Gastroenterology resident and member of the Y-ILCA Committee, we are joined by Jeroen Dekervel, Digestive On
Season 4 - Episode 1 In this new episode of ILCA’s Liver Cancer Podcast, we kick off our 2025 series with an insightful discussion on the latest advancements in hepatocellular carcinoma (HCC) surveillance. Hosted by Cosk
Season 3 - Episode 9 In this episode, sponsored by Roche, we delve into the groundbreaking findings from the IMbrave150 trial, focusing on the efficacy and safety of Atezolizumab plus Bevacizumab versus Sorafenib in pati
Season 3 - Epiosode 8 In this episode, sponsored by Roche, David Pinato and Manon Allaire delve into the use of real-world research data and its implications. They share insights from their professional experiences with
Season 3 - Episode 7 In this episode, Joana Espírito Santo and Julien Calderaro explore the diagnostic complexity and the treatment and prognosis pitfalls of combined hepatocellular-cholangiocarcinomas (cHCC-CCAs). They
In this episode, Joana Espírito Santo and Julien Calderaro explore the diagnostic complexity and the treatment and prognosis pitfalls of combined hepatocellular-cholangiocarcinomas (cHCC-CCAs). They reflect on the hetero
Season 3 - Episode 6 In this episode, Lorenza Rimassa, Andrew Moon, and Jakob Kather discuss ways to enhance tumor board effectiveness. Lorenza emphasizes the importance of multidisciplinary collaboration, Andrew highlig
Season 3 -Episode 5 Meet Antonio D'Alessio and Claudia Campani, two of the best oral presenters from the ILCA 2023 Annual Conference. Antonio will present and discuss his work "Predictors of response to neoadjuvant immun
Season 3 - Episode 4 In this episode, Dr Taizo Hibi and Dr Cristina Dopazo discuss a recent review article in Hepatoma Research titled: “Liver Transplantation for perihiliar cholangiocarcinoma: Do we need to move forward
Season 3 - Episode 3 This episode discusses a recent review article in Hepatoma Research titled: "Challenges and Barriers in Hepatocellular Carcinoma Surveillance for Patients with non-alcoholic Fatty Liver Disease" (now
In this episode, Drs. Maria Reig and Richard Finn will dive deep into the updates and groundbreaking research presented at the ASCO GI Meeting in January 2023. They will explore the latest advancements in the field of he
In this podcast, Lorenza Rimassa and Alejandro Forner summarize four abstracts orally presented during the ESMO annual congress held in Paris in September 2022. Three abstracts report the results of first-line phase 3 tr
In this podcast, Valerie Paradis and Maria Barcena Varela discuss four different papers presented at ILCA AC 2022. These interesting works have the aim to combine experimental models and studies of clinical patients and
In this episode David Pinato comments on the ILCA 2022 session on Diagnosis, Imaging and Biomarkers for HCC. Hear his considerations and analysis on novel biomarkers, protein biomarkers and gut microbiomes as potential s
Medical education is key to improve liver surgery as well as preparing surgical procedures and setting technological tools in advance. In this podcast Gonzalo Sapisochin and Eric Vibert will go through the surgical sessi
Hear all about the preliminary results of a real-life study, a new and promising therapeutical approach to HCC, the final results from FIGHT-202 and new presented data from the Phase 3 HIMALAYA Trial. In this episode, As
In this episode, Transplant Hepatologist at Royal Prince Alfred Hospital, Ken Liu, and Professor of Medicine at UT Southwestern Medical Center, Amit Singal, cover some of the highlights from the General Session 2: Epidem
Hepatocellular carcinoma is a major health problem worldwide, being the fifth most common cancer and the third among cancer-related deaths. Surgery represents the cornerstone treatment for early stages, and Minimally Inv
In this episode, Drs. Amit Singal and Marco Sanduzzi-Zamparelli summarize presentations and the discussion from the ILCA Single Topic Workshop: HCC Risk Stratification and Surveillance, which was held in Paris, France on
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Liver Cancer Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.
Liver Cancer Podcast is hosted by Unknown Host. The show is categorised under Business (non-profit) and has published 28 episodes.
Liver Cancer Podcast has published 28 episodes.
Liver Cancer Podcast regularly covers Business, Non-profit, Education. It sits in the Business category, with a non-profit focus.
Liver Cancer Podcast is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Liver Cancer Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Liver Cancer Podcast average 16 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Liver Cancer Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 3 days ago.